APA
Bonifazi F., Solano C., Wolschke C., Sessa M., Patriarca F., Zallio F., Nagler A., Selleri C., Risitano A. M., Messina G., Bethge W., Herrera P., Sureda A., Carella A. M., Cimminiello M., Guidi S., Finke J., Sorasio R., Ferra C., Sierra J., Russo D., Benedetti E., Milone G., Benedetti F., Heinzelmann M., Pastore D., Jurado M., Terruzzi E., Narni F., Völp A., Ayuk F., Ruutu T. & Kröger N. (20190215). Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study. : The Lancet. Haematology.
Chicago
Bonifazi Francesca, Solano Carlos, Wolschke Christine, Sessa Mariarosaria, Patriarca Francesca, Zallio Francesco, Nagler Arnon, Selleri Carmine, Risitano Antonio Maria, Messina Giuseppe, Bethge Wolfgang, Herrera Pilar, Sureda Anna, Carella Angelo Michele, Cimminiello Michele, Guidi Stefano, Finke Jürgen, Sorasio Roberto, Ferra Christelle, Sierra Jorge, Russo Domenico, Benedetti Edoardo, Milone Giuseppe, Benedetti Fabio, Heinzelmann Marion, Pastore Domenico, Jurado Manuel, Terruzzi Elisabetta, Narni Franco, Völp Andreas, Ayuk Francis, Ruutu Tapani and Kröger Nicolaus. 20190215. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study. : The Lancet. Haematology.
Harvard
Bonifazi F., Solano C., Wolschke C., Sessa M., Patriarca F., Zallio F., Nagler A., Selleri C., Risitano A. M., Messina G., Bethge W., Herrera P., Sureda A., Carella A. M., Cimminiello M., Guidi S., Finke J., Sorasio R., Ferra C., Sierra J., Russo D., Benedetti E., Milone G., Benedetti F., Heinzelmann M., Pastore D., Jurado M., Terruzzi E., Narni F., Völp A., Ayuk F., Ruutu T. and Kröger N. (20190215). Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study. : The Lancet. Haematology.
MLA
Bonifazi Francesca, Solano Carlos, Wolschke Christine, Sessa Mariarosaria, Patriarca Francesca, Zallio Francesco, Nagler Arnon, Selleri Carmine, Risitano Antonio Maria, Messina Giuseppe, Bethge Wolfgang, Herrera Pilar, Sureda Anna, Carella Angelo Michele, Cimminiello Michele, Guidi Stefano, Finke Jürgen, Sorasio Roberto, Ferra Christelle, Sierra Jorge, Russo Domenico, Benedetti Edoardo, Milone Giuseppe, Benedetti Fabio, Heinzelmann Marion, Pastore Domenico, Jurado Manuel, Terruzzi Elisabetta, Narni Franco, Völp Andreas, Ayuk Francis, Ruutu Tapani and Kröger Nicolaus. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study. : The Lancet. Haematology. 20190215.